Meridian Bioscience

Meridian Bioscience Market capitalization

The The market capitalization of Meridian Bioscience (VIVO) as of Oct 27, 2026 is 1.49 B USD. In the previous year, The market capitalization was 1.49 B USD — a change of 0.00% (lower).

Market capitalization

1.49 BUSD

YoY

0.00%

Last updated:

In 2022, Meridian Bioscience's market cap stood at 1.49 B USD, a 0.00% increase from the 1.49 B USD market cap in the previous year.

The Meridian Bioscience Market capitalization history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Market capitalization
Date
Market capitalization
Jan 1, 2015
1.49 B USD
Jan 1, 2016
1.49 B USD
Jan 1, 2017
1.49 B USD
Jan 1, 2018
1.49 B USD
Jan 1, 2019
1.49 B USD
Jan 1, 2020
1.49 B USD
Jan 1, 2021
1.49 B USD
Jan 1, 2022
1.49 B USD
The Meridian Bioscience Market capitalization history
YEARMarket capitalizationYoY
1.49 BUSD0.00%
1.49 BUSD0.00%
1.49 BUSD0.00%
1.49 BUSD0.00%
1.49 BUSD0.00%
1.49 BUSD0.00%
1.49 BUSD0.00%
1.49 BUSD0.00%
1.49 BUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Meridian Bioscience Stock analysis

What does Meridian Bioscience do? Meridian Bioscience Inc. is a global company specializing in the development, manufacture, and distribution of test kits for the diagnosis of infectious diseases and other medical conditions. The company was founded in 1976 by William J. Motto and initially focused on the development of enzyme immunoassays (EIA). Over the years, the company has grown and diversified its product offerings, becoming a leading provider of diagnostic test kits for acute and chronic medical conditions, infectious diseases, gastrointestinal infections, and virology. The company's success is attributed to its diverse range of test kits in various medical areas, including immunology, infectious diseases, sexually transmitted diseases, gastroenterology, and virology. Additionally, Meridian Bioscience Inc. stays up-to-date with the latest technological advancements in biotechnology to ensure the fast and effective performance of its tests. The company operates globally, collaborating with universities, research institutions, government agencies, and distributors to ensure the worldwide distribution and marketing of its products. In summary, Meridian Bioscience Inc. is an innovative company specializing in the development, manufacture, and distribution of test kits for the diagnosis of infectious diseases and other medical conditions. Its wide range of products, including immunology products, infectious disease diagnostics, sexually transmitted disease test kits, gastroenterology, virology, and molecular diagnostics, coupled with advanced technologies, provides fast, accurate, and reliable diagnostic support. Meridian Bioscience is one of the most popular companies on Eulerpool.

Market capitalization Details

Exploring Meridian Bioscience's Market Capitalization

Meridian Bioscience's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Meridian Bioscience's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Meridian Bioscience's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Meridian Bioscience’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Meridian Bioscience stock

The market capitalization of Meridian Bioscience is 1.49 B USD in 2022.

The market capitalization of Meridian Bioscience changed from 1.49 B USD to 1.49 B USD, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The market capitalization Meridian Bioscience since 2006 – with annual values, charts, and detailed analysis.

Market capitalization (German: Market capitalization, English: market capitalisation or market cap) is the calculated total value of all shares of a publicly traded company. The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company. It is determined by the supply and demand for the company's shares. Thus, market capitalization is significantly influenced by expectations in the stock market regarding the future earnings power of the company and, therefore, can be subject to significant fluctuations.

Number of shares * share price = market capitalization

To evaluate The market capitalization's USD, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for The market capitalization.

A 'good' USD varies by industry and company stage. On Eulerpool, you can compare The market capitalization's Meridian Bioscience with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Meridian Bioscience

All Key Metrics — Meridian Bioscience